Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Fox

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|December 18, 2020
Gene therapy for primary immunodeficienciesThomas A Fox, Claire Booth
Disease Models & Mechanisms|April 19, 2024
Improving access to gene therapy for rare diseasesThomas A Fox, Claire Booth
Rare Disease and Orphan Drugs Journal|February 16, 2026
Gene therapy for inborn errors of immunity: past progress, current status and future directionsRobert Torrance, Kate Orf, Thomas A Fox
The Clinical Teacher|May 10, 2017
The educational impact of experience overseasThomas A Fox, Ged Byrne, Lucie M Byrne-Davis
Leukemia Research Reports|February 24, 2022
Gilteritinib monotherapy as a transplant bridging option for high risk <i>FLT3</i>-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapyJames W Day, Thomas A Fox, Rajeev Gupta, et al.
Scientific Reports|June 9, 2021
Weather constraints on global drone flyabilityMozhou Gao, Chris H Hugenholtz, Thomas A Fox, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitroPratima Chowdary, Colleen Hamid, David Slatter, et al.
Journal of Clinical Immunology|January 6, 2025
Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Thomas A Fox, Valerie Massey, Charley Lever, et al.
Therapeutic Advances in Medical Oncology|November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort studyValerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.
British Journal of Haematology|July 4, 2023
Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccinationChristopher L Pinder, Dylan Jankovic, Thomas A Fox, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|December 18, 2020
Gene therapy for primary immunodeficienciesThomas A Fox, Claire Booth
Disease Models & Mechanisms|April 19, 2024
Improving access to gene therapy for rare diseasesThomas A Fox, Claire Booth
Rare Disease and Orphan Drugs Journal|February 16, 2026
Gene therapy for inborn errors of immunity: past progress, current status and future directionsRobert Torrance, Kate Orf, Thomas A Fox
The Clinical Teacher|May 10, 2017
The educational impact of experience overseasThomas A Fox, Ged Byrne, Lucie M Byrne-Davis
Leukemia Research Reports|February 24, 2022
Gilteritinib monotherapy as a transplant bridging option for high risk <i>FLT3</i>-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapyJames W Day, Thomas A Fox, Rajeev Gupta, et al.
Scientific Reports|June 9, 2021
Weather constraints on global drone flyabilityMozhou Gao, Chris H Hugenholtz, Thomas A Fox, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitroPratima Chowdary, Colleen Hamid, David Slatter, et al.
Journal of Clinical Immunology|January 6, 2025
Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Thomas A Fox, Valerie Massey, Charley Lever, et al.
Therapeutic Advances in Medical Oncology|November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort studyValerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.
British Journal of Haematology|July 4, 2023
Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccinationChristopher L Pinder, Dylan Jankovic, Thomas A Fox, et al.
Pageof 3